Monica Brenca

852 total citations
16 papers, 493 citations indexed

About

Monica Brenca is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Monica Brenca has authored 16 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Monica Brenca's work include Sarcoma Diagnosis and Treatment (10 papers), Cancer Mechanisms and Therapy (3 papers) and Chromatin Remodeling and Cancer (3 papers). Monica Brenca is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), Cancer Mechanisms and Therapy (3 papers) and Chromatin Remodeling and Cancer (3 papers). Monica Brenca collaborates with scholars based in Italy, Ukraine and Malaysia. Monica Brenca's co-authors include Roberta Maestro, Sabrina Rossi, Angelo Paolo Dei Tos, Maurizio Polano, Lucia Zanatta, Daniela Gasparotto, Laura Valori, Stefano Lamon, A R Bianco and Francesca De Micco and has published in prestigious journals such as Journal of Clinical Oncology, PLoS Genetics and The American Journal of Surgical Pathology.

In The Last Decade

Monica Brenca

16 papers receiving 488 citations

Peers

Monica Brenca
Prasuna Muppa United States
Monica Brenca
Citations per year, relative to Monica Brenca Monica Brenca (= 1×) peers Prasuna Muppa

Countries citing papers authored by Monica Brenca

Since Specialization
Citations

This map shows the geographic impact of Monica Brenca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Brenca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Brenca more than expected).

Fields of papers citing papers by Monica Brenca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Brenca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Brenca. The network helps show where Monica Brenca may publish in the future.

Co-authorship network of co-authors of Monica Brenca

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Brenca. A scholar is included among the top collaborators of Monica Brenca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Brenca. Monica Brenca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Righi, Alberto, Marta Sbaraglia, Marco Gambarotti, et al.. (2020). Primary Vascular Tumors of Bone. The American Journal of Surgical Pathology. 44(9). 1192–1203. 21 indexed citations
2.
Gasparotto, Daniela, Marta Sbaraglia, Sabrina Rossi, et al.. (2020). Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumors. JCI Insight. 5(22). 11 indexed citations
3.
Rossi, Sabrina, Monica Brenca, Lucia Zanatta, et al.. (2018). A Pediatric Intra-Axial Malignant SMARCB1-Deficient Desmoplastic Tumor Arising in Meningioangiomatosis. Journal of Neuropathology & Experimental Neurology. 77(10). 883–889. 8 indexed citations
4.
Urbini, Milena, Annalisa Astolfi, Valentina Indio, et al.. (2017). Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue. Oncotarget. 8(36). 60036–60045. 14 indexed citations
5.
Giorgio, Eros Di, Sabrina Rossi, Angelo Paolo Dei Tos, et al.. (2017). The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness. PLoS Genetics. 13(4). e1006752–e1006752. 38 indexed citations
6.
Stacchiotti, Silvia, Annalisa Astolfi, Alessandro Gronchi, et al.. (2016). Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial–Mesenchymal Transition–like Process and 22q Loss. Molecular Cancer Research. 14(9). 820–829. 23 indexed citations
7.
Provenzano, Salvatore, Roberta Maestro, Gian Paolo Dagrada, et al.. (2016). Sunitinib (SM) in advanced extraskeletal myxoid chondrosarcoma (EMC): Updated analysis in 11 patients (pts).. Journal of Clinical Oncology. 34(15_suppl). 11059–11059. 2 indexed citations
8.
Bozzi, Fabio, Silvia Brich, Gian Paolo Dagrada, et al.. (2016). Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework. Oncotarget. 7(46). 75503–75517. 14 indexed citations
9.
Brich, Silvia, Fabio Bozzi, Elena Conca, et al.. (2016). Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours. Oncotarget. 7(29). 45015–45026. 11 indexed citations
10.
Brenca, Monica & Roberta Maestro. (2015). Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives. Expert Review of Anticancer Therapy. 15(12). 1473–1488. 7 indexed citations
11.
Brenca, Monica, Sabrina Rossi, Maurizio Polano, et al.. (2015). Transcriptome sequencing identifies ETV6–NTRK3 as a gene fusion involved in GIST. The Journal of Pathology. 238(4). 543–549. 141 indexed citations
12.
Hindi, Nadia, Silvana Pilotti, Roberta Maestro, et al.. (2015). Sunitinib malate in advanced alveolar soft part sarcoma (ASPS): A final update after the closure of the named use program.. Journal of Clinical Oncology. 33(15_suppl). 10562–10562. 3 indexed citations
13.
Brenca, Monica, Mattia Boeri, Carla Verri, et al.. (2014). YAP1acts as oncogenic target of 11q22 amplification in multiple cancer subtypes. Oncotarget. 5(9). 2608–2621. 56 indexed citations
14.
Brenca, Monica, Sabrina Rossi, Elena Piccinin, et al.. (2013). SMARCB1 / INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ. Molecular Cancer Therapeutics. 12(6). 1060–1072. 31 indexed citations
15.
Modena, Piergiorgio, Iacopo Sardi, Monica Brenca, et al.. (2013). Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor. BMC Cancer. 13(1). 100–100. 7 indexed citations
16.
Quintavalle, Cristina, Monica Brenca, Francesca De Micco, et al.. (2011). In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. Cell Death and Disease. 2(5). e155–e155. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026